SMART therapy is for patients with moderate to severe asthma who need a combination treatment. This combined treatment consists of an inhaled corticosteroid and an inhaled long-acting beta-2 agonist (LABA). Under asthma guidelines, SMART therapy is recommended for people with moderate to severe asthma, including children ages 5 and older. It is considered an easier and patient friendly treatment plan to follow. In this webinar, learn about SMART therapy and other patient friendly asthma management strategies.
Speaker: Angela Hogan, MD
Dr. Hogan is double board certified in allergy and immunology and pediatrics. She practices at the Children’s Hospital of the King’s Daughter in Virginia. Dr. Hogan is passionate about community education in asthma and food allergies. She feels it is very important to not only get the correct diagnosis for food allergies but also important to understand the impact such a diagnosis has on the child and the family. She formed a regional food allergy support group called FASGOT.com, which helps healthcare providers, schools and families deal with food allergies. She is extensively involved in the education of the school nurses in the seven districts in her area and has organized outreach programs for community physicians. For Dr. Hogan, CHKD really is more than a hospital. It allows her to teach not only families but also future doctors in pediatrics and allergy. It supports her as she tries to work in the community, and it allows her to do clinical research. Dr. Hogan chairs the asthma committee of the American College of Allergy, Asthma, and Immunology.
This Advances webinar is in partnership with the American College of Allergy, Asthma & Immunology. ACAAI offers CMEs for physicians for this webinar. If you are a member of ACAAI, you can obtain CME through the member portal for Advances webinars.
All attendees will be offered a certificate of attendance. No other continuing education credit is provided.